Abstract: Abstract The invention discloses External Traditional Indian Herbal Medicinal Nasal Spray for Preventing Nasal Congestion, Common Cold, Sinus Pressure, and Preparation Method Thereof, belonging to the technical field of traditional Indian herbal medicinal formulation. The herbal nasal spray is prepared with either or all of the following raw materials in v/v percentage: Tulsi (Ocimum sanctum) 1-5%, Lavana (Saindhava lavana) 0.3-2%, Eucalyptus globulus 0.5- 5%, Capsicum minimum 0.02-2%, Mentha piperita 0.05-3%, Xylitol 2-6%. The nasal spray provided by the invention has beneficial effects on nasal congestion, common cold, and sinus pressure. The traditional Indian herbal medicine formula adopts authentic natural medicinal materials. The use of Spray formulation absorption rate is high because the contact area is greater to expose the herbal medication. The nasal spray is simple to operate, painless, convenient to store, quick onset of action, convenient to use, and free of toxic and side effects. The raw materials used for the formulation process are easily available
DESC:The invention discloses External Traditional Indian Herbal Medicinal Nasal Spray for
Preventing Nasal Congestion, Common Cold, Sinus Pressure, and Preparation Method
Thereof. India herbal phytoconstituents are used and deliver the medicament in spray foam.
This nasal spray is a metered dosage to deliver the actual amount of medicament. Spray form
shows an increase in the absorption rate and increased bioavailability. The nasal spray is simple
to operate, painless, convenient to store, quick onset of action, convenient to use, and free of
toxic and side effects. Nasal sprays are used for all age groups of people ,CLAIMS:1. An external traditional Indian herbal medicinal nasal spray for preventing nasal
congestion, common cold, sinus pressure, and Allergic rhinitis; The nasal spray is
simple to operate, painless, convenient to store, quick onset of action, convenient to
use, and free of toxic and side effects. The raw materials used for the formulation
process are easily available.
2. The composition of claim 1, where we use the traditional Indian herbal medication for
the preparation of nasal spray which is safe for adults and kids.
3. The composition of claim 1, Intended for topical nasal administration of medicament.
4. The composition of claim 1, is that Tulsi is used as an anti-inflammatory agent to treat
cough, runny nose, and throat irritation.
5. The composition of claim 1, wherein the formulation is a spray form of metered dose
which increases the Absorption of the phytoconstituents.
6. The composition of claim 5, higher absorption shows high bioavailability and produces
quick onset action.
7. The composition of claim 1, wherein the Eucalyptus presents antimicrobial properties.
Capsicum minimum represents to treatment of nasal decongestion and allergic rhinitis,
Menthol represents the mucosal irritant to treat stuffy nose.
8. The composition of claim 1, wherein Lavena uses to constrict the nasal mucosa to treat
nasal congestion. Xylitol has anti-bacterial and anti-inflammatory properties to inhibit
the growth of bacteria in stuffy noses.
9. The composition of claim 1, wherein all ingredients are Indian herbal medicament, its
free from harmful chemicals, simple to use, affordable, and used for all age groups of
people
| # | Name | Date |
|---|---|---|
| 1 | 202341065462-PROVISIONAL SPECIFICATION [28-09-2023(online)].pdf | 2023-09-28 |
| 2 | 202341065462-FORM 1 [28-09-2023(online)].pdf | 2023-09-28 |
| 3 | 202341065462-FIGURE OF ABSTRACT [28-09-2023(online)].pdf | 2023-09-28 |
| 4 | 202341065462-DRAWINGS [28-09-2023(online)].pdf | 2023-09-28 |
| 5 | 202341065462-DRAWING [02-08-2024(online)].pdf | 2024-08-02 |
| 6 | 202341065462-COMPLETE SPECIFICATION [02-08-2024(online)].pdf | 2024-08-02 |
| 7 | 202341065462-POA [23-04-2025(online)].pdf | 2025-04-23 |
| 8 | 202341065462-FORM 18 [23-04-2025(online)].pdf | 2025-04-23 |
| 9 | 202341065462-FORM 13 [23-04-2025(online)].pdf | 2025-04-23 |
| 10 | 202341065462-AMENDED DOCUMENTS [23-04-2025(online)].pdf | 2025-04-23 |